
Preparing for IVF or ICSI does not mean ordering the largest possible panel of laboratory tests.
The purpose of pretreatment assessment is to identify information that may actually change care: how the ovaries are expected to respond, whether there is a relevant uterine or tubal issue, whether male-factor infertility is present, and whether any medical condition could affect treatment or pregnancy.
Evaluation therefore starts with the couple's medical and reproductive history, followed by core tests and targeted investigations when clinically justified.
What Is Reviewed Before IVF or ICSI Testing?
The fertility team may review:
Female and male age.
Duration of infertility.
Menstrual pattern.
Previous pregnancies and miscarriages.
Previous IVF or ICSI cycles.
Previous oocyte and embryo numbers.
Surgeries.
Chronic diseases.
Current medications and supplements.
Male fertility history.
Previous semen analyses.
Relevant genetic or family history.
The appropriate workup should reflect the actual clinical problem rather than use the same list for every couple.
What Are the Main Female Tests Before IVF or ICSI?
Assessment usually focuses on:
Ovarian reserve and predicted response.
Ovarian and uterine ultrasound findings.
Relevant endocrine conditions.
General medical and procedural safety.
What Does AMH Tell Us Before IVF?
AMH is widely used to assess ovarian reserve and estimate expected response to ovarian stimulation.
It can help predict whether response may be relatively low, average or high and therefore contribute to stimulation planning.
However, AMH does not independently determine:
Egg quality.
Chromosome status.
Whether pregnancy is possible.
The chance of live birth.
Age remains essential when interpreting reproductive potential.
For a detailed explanation, read AMH Test: What Does Ovarian Reserve Mean?.
Does AMH Need to Be Tested on a Specific Cycle Day?
Usually not.
AMH can generally be measured at any point in the menstrual cycle.
Its interpretation should still consider:
Age.
AFC.
Hormonal contraception.
Previous ovarian surgery.
Endometriosis.
Previous stimulation response.
What Is AFC?
AFC, or antral follicle count, is measured by transvaginal ultrasound.
Along with AMH, it helps estimate ovarian response to stimulation.
Ultrasound can also assess:
Ovaries.
Cysts.
Endometriomas.
Uterine structure.
Endometrium.
Fibroids.
Other abnormalities when present.
AMH and AFC are useful predictors of oocyte yield but poor independent predictors of reproductive potential.
What About Basal FSH and Estradiol?
Basal FSH and estradiol may be measured together during the early follicular phase, commonly cycle days 2–4.
FSH can rise as ovarian reserve declines, although it has greater cycle-to-cycle variability than AMH.
Estradiol helps interpret FSH because an early estradiol rise may suppress FSH and make it appear deceptively normal.
No ovarian-reserve result should be interpreted in isolation.
Is LH Required for Every Woman?
No.
LH may be useful in selected endocrine or ovulatory evaluations, but it is not the principal marker of ovarian reserve.
The LH/FSH ratio should not be used by itself to diagnose PCOS.
PCOS assessment depends on the broader clinical picture, menstrual pattern, hyperandrogenism and ovarian findings rather than one hormone ratio.
Is TSH Important Before IVF?
TSH helps assess thyroid function.
Thyroid disorders may affect menstrual function, fertility and pregnancy.
If TSH is abnormal, additional testing such as free T4 may be appropriate depending on the clinical situation.
An isolated minor abnormality does not automatically mean an IVF cycle must be cancelled; management depends on severity and context.
Does Every Woman Need a Prolactin Test?
Not necessarily.
Prolactin is particularly relevant when there is:
Irregular menstruation.
Oligomenorrhea.
Amenorrhea.
Galactorrhea.
Another clinical reason to suspect hyperprolactinemia.
ASRM does not recommend prolactin as a routine infertility test for every woman without a relevant clinical indication.

Is Progesterone a Routine Pre-IVF Test?
Not as a universal baseline test for every patient.
Progesterone may be used in specific settings, such as assessing ovulation or during particular treatment protocols.
Its role is different from AMH and AFC in pretreatment ovarian-response assessment.
What About HbA1c and Glucose?
Metabolic assessment may be particularly important when a patient has:
Diabetes.
Prediabetes risk.
Obesity.
PCOS.
Insulin resistance.
Other metabolic risk factors.
Testing may include fasting glucose or HbA1c, with additional testing based on medical history.
The purpose is both treatment safety and healthier pregnancy preparation.
Are Vitamin D, B12, Ferritin and Folate Tests Mandatory?
Not for every IVF patient.
They may be appropriate when there is:
Known deficiency.
Anaemia.
Dietary concern.
Relevant symptoms.
Medical indications.
Folate is important in preconception care, but this does not mean every micronutrient requires routine testing before IVF.
Correcting a documented deficiency is different from using broad testing and supplements as an unproven IVF success strategy.
What Tests Does the Male Partner Need?
Male evaluation should take place in parallel with female evaluation.
The main first-line test is:
Semen analysis.
It typically assesses:
Semen volume.
Sperm concentration.
Motility.
Morphology.
Other laboratory parameters.
The result may identify a male factor that affects treatment selection or requires further evaluation.
Is One Semen Analysis Enough?
Not always.
Semen parameters can vary.
If the result is abnormal or inconsistent with the clinical history, repeating the test may be useful.
Temporary changes may occur after:
Fever.
Infection.
Medication changes.
Heat exposure.
Other medical events.
Does Every Man Need FSH, LH and Testosterone?
No.
Male hormonal assessment is more useful when there is:
Significant oligozoospermia.
Azoospermia.
Low libido.
Symptoms of testosterone deficiency.
Other evidence of endocrine dysfunction.
AUA/ASRM guidance does not consider FSH and testosterone universal first-line tests for every infertile man; they are targeted according to semen results and clinical findings.
Does Every Man Need Sperm DNA Fragmentation Testing Before ICSI?
No.
Sperm DNA fragmentation provides information beyond routine semen analysis, but it is not recommended as a universal initial test for every infertile couple.
It may be considered in selected situations based on reproductive history and previous treatment outcomes.
AUA/ASRM guidance specifically advises against routine sperm DNA fragmentation testing in the initial evaluation of all infertile couples.
For more detail, read Sperm DNA Fragmentation Test: Why Is It Important?.
Is Tubal Testing Required Before IVF?
Not every IVF patient requires the same tubal workup.
Tubal patency is important during general infertility evaluation, especially when natural conception or IUI remains an option.
Before IVF, a specific issue such as hydrosalpinx may be particularly relevant because it can change treatment planning.
The need for HSG or another tubal assessment depends on:
Medical history.
Previous imaging.
Previous surgery.
Ultrasound findings.
Treatment plan.
Does HSG Detect Every Uterine Problem?
No.
HSG can provide information about the tubes and uterine cavity outline, but it is not the best test for every uterine abnormality.
Depending on the concern, assessment may involve:
Transvaginal ultrasound.
Saline infusion sonography.
Hysteroscopy.
Does Every Woman Need Hysteroscopy Before IVF?
No.
Diagnostic hysteroscopy should not be treated as a universal requirement before a first IVF cycle when there is no clinical indication.
It may be considered when there is suspicion of:
Endometrial polyps.
Submucosal fibroids.
Intrauterine adhesions.
Abnormal bleeding.
Uterine-cavity abnormalities.
Other relevant findings.
Read more about Diagnostic Hysteroscopy and IVF Failure.
What General Safety Tests May Be Required?
Requirements vary between clinics and countries.
Depending on the patient and local protocol, testing may include:
Complete blood count.
Blood group.
Infectious-disease screening.
Tests related to chronic disease.
Anaesthesia assessment where relevant.
Cervical screening if due.
Not all of these are infertility tests. Some are required for procedural and pregnancy safety.
What Infectious-Disease Screening Is Required?
Fertility centres commonly require specific infectious-disease tests before handling or storing reproductive samples.
Depending on local rules, testing may include:
HIV.
Hepatitis B.
Hepatitis C.
Syphilis.
Other locally required tests.
The exact panel and validity period can vary.
Does Every Couple Need a Karyotype?
No.
Karyotyping is not a universal pre-IVF test.
It may be more relevant in selected situations such as:
Certain severe male-factor conditions.
Azoospermia.
Recurrent pregnancy loss in an appropriate context.
Family or clinical history suggesting chromosomal disease.
Selected cases of premature ovarian insufficiency.
Genetic testing should answer a specific clinical question rather than be ordered automatically because IVF is planned.
What About Y-Chromosome Microdeletion and CFTR Testing?
These are examples of targeted genetic tests.
They may become relevant in selected men with:
Severe oligozoospermia.
Azoospermia.
Congenital absence of the vas deferens.
Suspected obstructive azoospermia.
AUA/ASRM recommendations, for example, specifically link CFTR testing to vasal agenesis and idiopathic obstructive azoospermia rather than all ICSI patients.
Does PGT Require Special Testing Before IVF?
It depends on the type of PGT.
For PGT-M because of a known inherited disorder, the couple may require:
Confirmation of the genetic variant.
Genetic counselling.
Laboratory preparation before treatment.
PGT-A is different and does not mean every patient requires extensive personal genetic testing before ovarian stimulation.
Does Every IVF Patient Need Thrombophilia Testing?
No.
Thrombophilia testing may be appropriate when there is:
Personal thrombotic history.
Significant family history.
A specific reproductive or medical indication.
Routine broad thrombophilia panels for every IVF patient may generate findings that do not change management.
Are Immune Tests or NK-Cell Tests Routine Before IVF?
No.
Broad immune testing, including tests such as NK-cell assessment or other immune panels, is not a routine component of pretreatment IVF evaluation for every patient.
A test should ideally have a clear clinical question and a result that can meaningfully alter treatment.
Does Every Patient Need Antiphospholipid Testing?
No.
Antiphospholipid syndrome testing is generally considered in appropriate clinical contexts such as recurrent pregnancy loss or relevant medical history.
It should not be automatically added to every IVF preparation panel.

Do All Results Need to Be Perfect Before Treatment?
No.
A laboratory value outside the reference range does not automatically mean treatment must be delayed.
The fertility team asks:
Does it affect patient safety?
Does it change stimulation?
Must it be treated first?
Can management occur alongside treatment?
Would delay matter because of age or ovarian reserve?
Tests should guide decisions rather than function as pass-or-fail barriers.
What If AMH Is Very Low?
Very low AMH may predict a lower ovarian response.
It does not mean pregnancy is impossible and should not be used alone to deny fertility treatment.
ASRM notes that ovarian-reserve markers are substantially better predictors of oocyte yield than independent predictors of pregnancy potential.
What If AMH Is High?
High AMH may indicate a strong response to stimulation, particularly in some women with PCOS.
This can affect dosing and OHSS-prevention strategies.
A high AMH result therefore does not simply mean “better fertility”; it is information for treatment planning.
Is Lifestyle Part of IVF Preparation?
Yes, but it should be discussed realistically.
Preparation may include reviewing:
Smoking.
Body weight.
Sleep.
Exercise.
Alcohol.
Chronic disease control.
Medications and supplements.
Healthy changes can support overall reproductive and pregnancy health, but lifestyle alone cannot correct blocked tubes, severe male-factor infertility or diminished ovarian reserve.
For more information, see Lifestyle Habits That Affect Fertility.
Should All Medications and Supplements Be Stopped?
No.
The couple should provide a complete list of:
Prescription medications.
Hormones.
Supplements.
Herbal products.
Some can continue, while others may need adjustment.
Essential treatment for chronic disease should never be stopped without appropriate medical advice.
What Should You Bring to the First IVF Consultation?
Useful records include:
Previous AMH and hormone results.
Ultrasound reports.
HSG if previously performed.
Semen analyses.
Previous IVF or ICSI records.
Embryology reports.
Previous PGT results.
Pregnancy and miscarriage records.
Surgical reports.
Current medication list.
Relevant genetic results.
Detailed previous cycle records can be especially valuable when deciding how to modify the next treatment.
Must Every Test Be Repeated?
Not necessarily.
Some results remain useful longer than others.
Whether a test needs repeating depends on:
How old the result is.
Changes in health.
Clinic policy.
Treatment timing.
Laboratory or legal requirements.
Existing records should therefore be reviewed before repeating large panels unnecessarily.
Routine Tests vs Targeted Tests
Common or Core Assessments
Depending on the patient, these may include:
AMH/AFC.
Ultrasound.
TSH.
Semen analysis.
General safety assessment.
Required infectious-disease tests.
Targeted Tests
These may include:
Prolactin.
Male hormone testing.
Sperm DNA fragmentation.
Hysteroscopy.
Karyotype.
Y-chromosome microdeletion.
CFTR testing.
Thrombophilia or antiphospholipid evaluation.
Other specialised investigations.
The key distinction is that a targeted test is ordered because its result can realistically change management.
Common Mistakes During IVF Preparation
Common mistakes include:
Ordering the same large test panel for every couple.
Treating AMH as a direct egg-quality or pregnancy test.
Diagnosing PCOS from the LH/FSH ratio alone.
Ordering prolactin or immune tests routinely without indication.
Delaying male evaluation until the female workup is complete.
Repeating recent tests without reviewing existing records.
Delaying treatment because of minor laboratory abnormalities while ignoring age and time.
Conclusion
Preparing for IVF or ICSI should not mean undergoing every available test.
A good pretreatment evaluation focuses on information that can actually change management: ovarian reserve, ultrasound findings, semen analysis, relevant endocrine conditions, general health and uterine or tubal assessment when indicated.
More specialised investigations—such as sperm DNA fragmentation, karyotype, thrombophilia testing, immune testing or hysteroscopy—should be used selectively rather than routinely for every patient.
The goal is not to make every laboratory result “perfect.” It is to identify what needs treatment, what affects safety, what changes the stimulation strategy and what can be monitored without delaying care unnecessarily.
If you are preparing for IVF or ICSI and want to know which tests are actually appropriate for you rather than completing an indiscriminate test panel, contact Safemedigo via WhatsApp to book a fertility consultation and review your existing results before treatment.
Frequently Asked Questions
What are the main tests before IVF or ICSI?
They vary by patient but commonly include ovarian-reserve assessment with AMH/AFC, ultrasound, semen analysis, TSH and relevant general safety tests.
Does AMH need to be tested on cycle day 2 or 3?
No. AMH can usually be measured on any cycle day, while basal FSH and estradiol are generally assessed early in the cycle.
Does every man need sperm DNA fragmentation testing before ICSI?
No. It is not a universal first-line test but may be useful in selected clinical situations.
Is hysteroscopy required before a first IVF cycle?
No. It is generally used when there is a specific reason to investigate the uterine cavity.
Do all test results need to be completely normal before IVF starts?
No. Some abnormalities require treatment, while others can be monitored or managed without delaying therapy.






.webp&w=1920&q=70)